AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31899950 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelleted diet
Number of subjects: 360
Study 31899950 — intervention group
Group type: EXPERIMENTAL
Intervention: Mash diet
Number of subjects: 360
Study 31899950 — intervention group
Group type: COMPARATOR
Intervention: Wheat-based diet
Number of subjects: 360
Study 31899950 — intervention group
Group type: EXPERIMENTAL
Intervention: Cereal type and feed form interaction
Number of subjects: 360
Study 30833375 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-Monitoring of Blood Glucose (SMBG) ≥80%
Number of subjects: 699
Study 30833375 — intervention group
Group type: COMPARATOR
Intervention: Self-Monitoring of Blood Glucose (SMBG) <80%
Number of subjects: 699
Study 30833375 — intervention group
Group type: EXPERIMENTAL
Intervention: SMBG% median
Number of subjects: 699
Study 30833375 — intervention group
Group type: EXPERIMENTAL
Intervention: HbA1c
Number of subjects: 699
Study 28833481 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of medications taken
Number of subjects: 0
Study 28833481 — intervention group
Group type: EXPERIMENTAL
Intervention: Variability in HbA1c
Number of subjects: 0
Study 28833481 — intervention group
Group type: EXPERIMENTAL
Intervention: Total comorbidities
Number of subjects: 0
Study 28833481 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher systolic blood pressure
Number of subjects: 0
Study 28833481 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher diastolic blood pressure
Number of subjects: 0
Study 28833481 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of anti-hypertensives
Number of subjects: 0
Study 26465253 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifocal IOLs (AcrySof IQ ReSTOR toric or nontoric)
Number of subjects: 208
Study 26465253 — intervention group
Group type: COMPARATOR
Intervention: Monofocal IOLs (nontoric only)
Number of subjects: 208
Study 23966058 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight vest (10 kg) during exercise testing
Number of subjects: 17
Study 23966058 — intervention group
Group type: COMPARATOR
Intervention: Weight reduction (WR) through caloric restriction
Number of subjects: 17
Study 20506126 — intervention group
Group type: EXPERIMENTAL
Intervention: NEVO™ sirolimus-eluting stent with biodegradable polymer
Number of subjects: 1
Study 19330931 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus GG (LGG) supplementation with standard triple therapy (amoxicillin 25 mg/kg twice per day, clarithromycin 10 mg/kg twice per day, omeprazole 0.5 mg/kg twice per day)
Number of subjects: 83
Study 19330931 — intervention group
Group type: COMPARATOR
Intervention: Placebo with standard triple therapy (amoxicillin 25 mg/kg twice per day, clarithromycin 10 mg/kg twice per day, omeprazole 0.5 mg/kg twice per day)
Number of subjects: 83
Study 19330931 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus GG (LGG) supplementation
Number of subjects: 83
Study 19330931 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study 17595475 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical diclofenac 0.1%
Number of subjects: 43
Study 17595475 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone 0.1%
Number of subjects: 43
Study 14987264 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidermolysis bullosa simplex (EBS)
Number of subjects: 140
Study 14987264 — intervention group
Group type: EXPERIMENTAL
Intervention: Dominant dystrophic EB (DDEB)
Number of subjects: 140
Study 14987264 — intervention group
Group type: EXPERIMENTAL
Intervention: Junctional EB (JEB)
Number of subjects: 140
Study 14987264 — intervention group
Group type: EXPERIMENTAL
Intervention: Recessive dystrophic EB (RDEB)
Number of subjects: 140
Study 14987264 — intervention group
Group type: EXPERIMENTAL
Intervention: JEB-Herlitz
Number of subjects: 140
Study 14987264 — intervention group
Group type: EXPERIMENTAL
Intervention: RDEB-Hallopeau-Siemens
Number of subjects: 140
Study 14987264 — intervention group
Group type: EXPERIMENTAL
Intervention: JEB-non-Herlitz
Number of subjects: 140
Study 14987264 — intervention group
Group type: EXPERIMENTAL
Intervention: Other RDEB subtypes
Number of subjects: 140
Study 11120491 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold knife surgical excision
Number of subjects: 59
Study 9873261 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood donors
Number of subjects: 968
Study 9873261 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemodialysis patients
Number of subjects: 968
Study 9873261 — intervention group
Group type: EXPERIMENTAL
Intervention: Children infected with HCV via blood transfusion
Number of subjects: 968
Study 7761553 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextroamphetamine
Number of subjects: 0
Study 7761553 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 0
Study 7761553 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 2723127 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine 0.3 mg and saline
Number of subjects: 6
Study 2723127 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine 0.3 mg and naloxone 0.6 mg
Number of subjects: 6
Study 2723127 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine 0.3 mg and naloxone 0.45 mg
Number of subjects: 6
Study 2723127 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine 0.3 mg and naloxone 0.3 mg
Number of subjects: 6
Study 2723127 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine 0.3 mg and naloxone 0.15 mg
Number of subjects: 6
Study 30867017 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-min treadmill walking program (Ex)
Number of subjects: 372
Study 30867017 — intervention group
Group type: EXPERIMENTAL
Intervention: Joint mobilisation (MB) of the thoracic spine and ribs plus the same walking program (MB + Ex)
Number of subjects: 372
Study 30867017 — intervention group
Group type: EXPERIMENTAL
Intervention: Joint manipulation (MT) of the thoracic spine and ribs plus the same walking program (MT + Ex)
Number of subjects: 372
Study 30867017 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 372
Study 29794761 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional acupuncture + thread embedding acupuncture
Number of subjects: 38
Study 29794761 — intervention group
Group type: COMPARATOR
Intervention: Conventional acupuncture
Number of subjects: 38
Study 26521178 — intervention group
Group type: EXPERIMENTAL
Intervention: MDMA (125 mg)
Number of subjects: 15
Study 24564568 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand tapping
Number of subjects: 237
Study 22271702 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient, oral amoxicillin plus ciprofloxacin
Number of subjects: 62
Study 22271702 — intervention group
Group type: COMPARATOR
Intervention: Continued standard treatment (intravenous antimicrobial therapy)
Number of subjects: 62
Study 20010073 — intervention group
Group type: EXPERIMENTAL
Intervention: Planned treatment interruptions (PTI)
Number of subjects: 109
Study 20010073 — intervention group
Group type: COMPARATOR
Intervention: Continuous therapy
Number of subjects: 109
Study 17187491 — intervention group
Group type: EXPERIMENTAL
Intervention: Valproate
Number of subjects: 0
Study 17187491 — intervention group
Group type: EXPERIMENTAL
Intervention: Valproate combined with lithium or antipsychotic drugs
Number of subjects: 0
Study 17187491 — intervention group
Group type: COMPARATOR
Intervention: Divalproex
Number of subjects: 0
Study 17187491 — intervention group
Group type: COMPARATOR
Intervention: Valproate (serum levels 75-99 microg/ml)
Number of subjects: 0
Study 16004253 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium carbonate/perlite whitening toothpaste
Number of subjects: 25
Study 16004253 — intervention group
Group type: EXPERIMENTAL
Intervention: Silica containing whitening toothpaste
Number of subjects: 25
Study 12235618 — intervention group
Group type: EXPERIMENTAL
Intervention: Inpatient rehabilitation
Number of subjects: 0
Study 12235618 — intervention group
Group type: COMPARATOR
Intervention: Home discharge
Number of subjects: 0
Study 10378906 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma volume expansion (PVexp) with 6% dextran
Number of subjects: 9
Study 10378906 — intervention group
Group type: COMPARATOR
Intervention: Sham plasma volume expansion (Sham)
Number of subjects: 9
Study 10378906 — intervention group
Group type: COMPARATOR
Intervention: Restoration of normocythemia
Number of subjects: 9
Study 10378906 — intervention group
Group type: COMPARATOR
Intervention: Reestablishment of normocythemia
Number of subjects: 9
Study 7758641 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal hysterectomy with unilateral oophorectomy
Number of subjects: 40
Study 7758641 — intervention group
Group type: COMPARATOR
Intervention: Abdominal hysterectomy only (preservation of both ovaries)
Number of subjects: 40
Study 2129317 — intervention group
Group type: EXPERIMENTAL
Intervention: pentaerythril tetranitrate (PETN)
Number of subjects: 34
Study 2129317 — intervention group
Group type: EXPERIMENTAL
Intervention: isosorbide dinitrate (ISDN)
Number of subjects: 34
Study 2129317 — intervention group
Group type: EXPERIMENTAL
Intervention: oral nitrate therapy
Number of subjects: 34
Study 7275281 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 ml of stored serum Biseko on the day of operation and the first postoperative day
Number of subjects: 30
Study 7275281 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 30712946 — intervention group
Group type: EXPERIMENTAL
Intervention: Living Successfully with Low Vision (LSLV) program, N = 83
Number of subjects: 165
Study 30712946 — intervention group
Group type: COMPARATOR
Intervention: Usual care (LV aid training only), N = 82
Number of subjects: 165
Study 28290144 — intervention group
Group type: EXPERIMENTAL
Intervention: Loss-framed message emphasizing the harms of smoking
Number of subjects: 279
Study 28290144 — intervention group
Group type: COMPARATOR
Intervention: Gain-framed message communicating the benefits of avoiding smoking
Number of subjects: 279
Study 28290144 — intervention group
Group type: COMPARATOR
Intervention: Neutral message
Number of subjects: 279
Study 25791462 — intervention group
Group type: COMPARATOR
Intervention: OCP alone (n=25)
Number of subjects: 50
Study 25791462 — intervention group
Group type: EXPERIMENTAL
Intervention: OCP combined with metformin (n=25)
Number of subjects: 50
Study 22717305 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-hour preprocedural intravenous hydration with isotonic saline (5h-HS)
Number of subjects: 122
Study 22717305 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-hour preprocedural intravenous hydration with isotonic saline (20h-HS)
Number of subjects: 122
Study 21129991 — intervention group
Group type: EXPERIMENTAL
Intervention: Biatrial reduction with reef‐imbricate suture technique and aggressive postoperative pharmacological therapy
Number of subjects: 322
Study 21129991 — intervention group
Group type: COMPARATOR
Intervention: Maze procedure alone
Number of subjects: 322
Study 20027097 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (8 mg intravenously)
Number of subjects: 70
Study 20027097 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 17474814 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine 40 to 120 mg/day
Number of subjects: 146
Study 17474814 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 146
Study 15191378 — intervention group
Group type: EXPERIMENTAL
Intervention: Gatifloxacin 400 mg once-daily for 5-10 days
Number of subjects: 462
Study 15191378 — intervention group
Group type: COMPARATOR
Intervention: Co-amoxiclav 500 mg + clavulanic acid 125 mg three-times-daily for 5-10 days
Number of subjects: 462
Study 11159231 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol
Number of subjects: 53
Study 11159231 — intervention group
Group type: COMPARATOR
Intervention: Remifentanil
Number of subjects: 53
Study 9491502 — intervention group
Group type: EXPERIMENTAL
Intervention: Two doses of a three-component acellular pertussis vaccine
Number of subjects: 248
Study 9491502 — intervention group
Group type: EXPERIMENTAL
Intervention: Three doses of a five-component acellular pertussis vaccine
Number of subjects: 248
Study 9491502 — intervention group
Group type: EXPERIMENTAL
Intervention: Three doses of a three-component acellular pertussis vaccine
Number of subjects: 248
Study 9491502 — intervention group
Group type: EXPERIMENTAL
Intervention: Two doses of a five-component acellular pertussis vaccine
Number of subjects: 248
Study 8141107 — intervention group
Group type: COMPARATOR
Intervention: Ondansetron alone (O)
Number of subjects: 75
Study 8141107 — intervention group
Group type: COMPARATOR
Intervention: Ondansetron plus dexamethasone (OD)
Number of subjects: 75
Study 8141107 — intervention group
Group type: COMPARATOR
Intervention: Ondansetron plus dexamethasone plus lorazepam (ODA)
Number of subjects: 75
Study 8141107 — intervention group
Group type: COMPARATOR
Intervention: Three-drug combination (ODA)
Number of subjects: 75
Study 8141107 — intervention group
Group type: COMPARATOR
Intervention: Two-drug combination (OD)
Number of subjects: 75
Study 3320274 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% oxygen at 2 ATA for 90 minutes daily for 20 sessions
Number of subjects: 120
Study 3320274 — intervention group
Group type: COMPARATOR
Intervention: Placebo therapy with air using a simulated compression procedure
Number of subjects: 120
Study 30166311 — intervention group
Group type: EXPERIMENTAL
Intervention: Online cognitive behaviour therapy for insomnia (CBT-I)
Number of subjects: 1500
Study 30166311 — intervention group
Group type: COMPARATOR
Intervention: Online patient education about sleep (PE)
Number of subjects: 1500
Study 27072573 — intervention group
Group type: EXPERIMENTAL
Intervention: Online CBT with therapist telephone support
Number of subjects: 60
Study 27072573 — intervention group
Group type: COMPARATOR
Intervention: Online CBT with no therapist
Number of subjects: 60
Study 24830830 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 g of fish oil
Number of subjects: 160
Study 24830830 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 g of fish oil plus a multivitamin
Number of subjects: 160
Study 24830830 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 g of fish oil plus a multivitamin
Number of subjects: 160
Study 24830830 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study 24830830 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 160
Study 24830830 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 g fish oil multivitamin combination
Number of subjects: 160
Study 23453283 — intervention group
Group type: EXPERIMENTAL
Intervention: Unconditional Cash Transfers (UCT)
Number of subjects: 4043
Study 23453283 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditional Cash Transfers (CCT)
Number of subjects: 4043
Study 23453283 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 4043
Study 16148589 — intervention group
Group type: EXPERIMENTAL
Intervention: travoprost 0.004%/timolol 0.5% fixed combination
Number of subjects: 316
Study 16148589 — intervention group
Group type: COMPARATOR
Intervention: Concomitant administration of travoprost 0.004% and timolol 0.5%
Number of subjects: 316
Study 11991670 — intervention group
Group type: EXPERIMENTAL
Intervention: TGFbeta1 in human milk
Number of subjects: 80
Study 11991670 — intervention group
Group type: EXPERIMENTAL
Intervention: TGFbeta2 in human milk
Number of subjects: 80
Study 11991670 — intervention group
Group type: EXPERIMENTAL
Intervention: TGFbeta1 in plasma
Number of subjects: 80
Study 11991670 — intervention group
Group type: EXPERIMENTAL
Intervention: TGFbeta2 in plasma
Number of subjects: 80
Study 11991670 — intervention group
Group type: EXPERIMENTAL
Intervention: Ratio of TGFbeta1 to TGFbeta2 in milk
Number of subjects: 80
Study 11991670 — intervention group
Group type: EXPERIMENTAL
Intervention: Ratio of TGFbeta1 to TGFbeta2 in plasma
Number of subjects: 80
Study 11991670 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between TGFbeta in milk and plasma
Number of subjects: 80
Study 10049962 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-daily dosing (ODD) of gentamicin at 4 mg/kg
Number of subjects: 55
Study 10049962 — intervention group
Group type: COMPARATOR
Intervention: Twice-daily dosing (TDD) of gentamicin at 2.5 mg/kg every 12 hours
Number of subjects: 55
Study 7747292 — intervention group
Group type: EXPERIMENTAL
Intervention: New empirical antibiotic regimen
Number of subjects: 50
Study 7747292 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger age
Number of subjects: 50
Study 7747292 — intervention group
Group type: COMPARATOR
Intervention: Control group (30 randomly chosen controls)
Number of subjects: 50
Study 2040893 — intervention group
Group type: EXPERIMENTAL
Intervention: Agar dilution techniques
Number of subjects: 90
Study 2040893 — intervention group
Group type: EXPERIMENTAL
Intervention: Microbroth dilution techniques
Number of subjects: 90
Study 2040893 — intervention group
Group type: EXPERIMENTAL
Intervention: Agar methods with 64 micrograms/ml breakpoint
Number of subjects: 90
Study 2040893 — intervention group
Group type: EXPERIMENTAL
Intervention: Broth disk elution procedure
Number of subjects: 90
Study 6785805 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic group received diazepam for 21 days
Number of subjects: 30
Study 6785805 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute group received diazepam at session 4
Number of subjects: 30
Study 6785805 — intervention group
Group type: COMPARATOR
Intervention: Control group received placebo only
Number of subjects: 30
Study 6785805 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic group over sessions
Number of subjects: 30
Study 6785805 — intervention group
Group type: EXPERIMENTAL
Intervention: Withdrawal from chronic group
Number of subjects: 30
Study 31793347 — intervention group
Group type: EXPERIMENTAL
Intervention: Collar-fitted stem
Number of subjects: 50
Study 31793347 — intervention group
Group type: COMPARATOR
Intervention: Collarless stem
Number of subjects: 50
Study 31621671 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose dexamethasone
Number of subjects: 20
Study 31621671 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo (nonsteroid group)
Number of subjects: 20
Study 28244413 — intervention group
Group type: EXPERIMENTAL
Intervention: Earlier presentation of trial information at appointments (5 vs 3 for oligometastatic protocol, 4 vs 3 for NSCLC protocol, 3 vs 2 for esophageal protocol)
Number of subjects: 309
Study 25203817 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-volume sprint interval training (SIT) for 2 weeks (6 sessions of 4-6 maximal 30-s sprints)
Number of subjects: 23
Study 25203817 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-volume sprint interval training (SIT) for 5 weeks (1 SIT session/week)
Number of subjects: 23
Study 25203817 — intervention group
Group type: COMPARATOR
Intervention: Regular aerobic training (Control)
Number of subjects: 23
Study 24060059 — intervention group
Group type: EXPERIMENTAL
Intervention: Responsive Classroom (RC) approach
Number of subjects: 0
Study 24060059 — intervention group
Group type: EXPERIMENTAL
Intervention: Responsive Classroom (RC) practices
Number of subjects: 0
Study 24060059 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 21166852 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 300 mg/day
Number of subjects: 317
Study 21166852 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 600 mg/day
Number of subjects: 317
Study 21166852 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 317
Study 18373615 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 28
Study 16836554 — intervention group
Group type: EXPERIMENTAL
Intervention: T-shirt incentive
Number of subjects: 6919
Study 16836554 — intervention group
Group type: EXPERIMENTAL
Intervention: Script A (patient story)
Number of subjects: 6919
Study 16836554 — intervention group
Group type: COMPARATOR
Intervention: E-mail recruitment
Number of subjects: 6919
Study 12780716 — intervention group
Group type: EXPERIMENTAL
Intervention: G. biloba extract 40 mg three times daily
Number of subjects: 47
Study 12780716 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study 11049008 — intervention group
Group type: EXPERIMENTAL
Intervention: tilidine/naloxone
Number of subjects: 12
Study 11049008 — intervention group
Group type: COMPARATOR
Intervention: bromfenac
Number of subjects: 12
Study 9493478 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine XR
Number of subjects: 0
Study 9493478 — intervention group
Group type: COMPARATOR
Intervention: Venlafaxine IR
Number of subjects: 0
Study 8404553 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovie electrocautery technique
Number of subjects: 29
Study 8404553 — intervention group
Group type: COMPARATOR
Intervention: Epinephrine-injection technique
Number of subjects: 29
Study 3739817 — intervention group
Group type: EXPERIMENTAL
Intervention: Social Skills Training Group (SSTG)
Number of subjects: 24
Study 3739817 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 24
Study 30524137 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic inhibition of PCSK9
Number of subjects: 72385
Study 30524137 — intervention group
Group type: COMPARATOR
Intervention: Statin therapy
Number of subjects: 72385
Study 27449641 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional treatment plus dexamethasone (20 mg iv from day 1 to day 5, and 10 mg iv from day 6 to day 10)
Number of subjects: 314
Study 27449641 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment without dexamethasone
Number of subjects: 314
Study 25023370 — intervention group
Group type: EXPERIMENTAL
Intervention: Real rTMS of left DLPFC (+C/R)
Number of subjects: 55
Study 25023370 — intervention group
Group type: EXPERIMENTAL
Intervention: Sham rTMS of left DLPFC (+C/S)
Number of subjects: 55
Study 25023370 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS of left DLPFC (-C/S)
Number of subjects: 55
Study 25023370 — intervention group
Group type: EXPERIMENTAL
Intervention: Real rTMS of left DLPFC (-C/R)
Number of subjects: 55
Study 22704744 — intervention group
Group type: EXPERIMENTAL
Intervention: Graphic warning labels
Number of subjects: 200
Study 22704744 — intervention group
Group type: COMPARATOR
Intervention: Text-only warning labels
Number of subjects: 200
Study 20222964 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient treatment feasibility as perceived by physicians
Number of subjects: 0
Study 20222964 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient treatment feasibility as perceived by nurses
Number of subjects: 0